Research programme: small molecules therapeutics - Kojin Therapeutics
Latest Information Update: 28 Jul 2025
At a glance
- Originator Kojin Therapeutics
- Class Anti-ischaemics; Antifibrotics; Antineoplastics; Small molecules
- Mechanism of Action Ferroptosis modulators; Ferroptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer; Fibrosis; Immunological disorders; Ischaemia; Neurodegenerative disorders
Most Recent Events
- 28 Jul 2025 No recent reports of development identified for research development in Cancer in USA
- 28 Jul 2025 No recent reports of development identified for research development in Fibrosis in USA
- 28 Jul 2025 No recent reports of development identified for research development in Immunological-disorders in USA